The industry might be asking why would the Department conduct the review after its interpretation of the criteria has already changed? Individual companies might be asking why the new interpretation has not applied to their requests? …
New Stories
-
PBAC Chair: Any change ultimately a matter for government
August 17, 2018 - - Latest News -
Government unhappy as big day arrives
August 17, 2018 - - Latest News -
Orphan designation change 'another barrier'
August 17, 2018 - - Latest News -
Industry firmly split on rebate reform model
August 17, 2018 - - Latest News -
Pfizer's 'celebrity doctor' on humanising the industry
August 16, 2018 - - PharmaDispatch Executive -
Patient access at risk over PBAC fee waiver
August 16, 2018 - - Latest News -
Investors cheer CSL result and outlook
August 16, 2018 - - Latest News